Last updated: July 28, 2025
Introduction
Patent WO2014124464, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. As a key component of worldwide patent filings, WO2014124464 exemplifies innovative efforts in drug development, with implications for market exclusivity, competitive positioning, and intellectual property strategy. This analysis provides a detailed examination of the patent’s scope, claims, and the broader patent landscape, equipping industry professionals with insights into its strategic value.
Patent Overview and Bibliographic Data
WO2014124464 is classified under the international patent classification (IPC) codes that indicate its pharmaceutical or chemical nature. While the exact inventors and applicants are typically listed on the WIPO database, similar patents are often held by major pharmaceutical companies or biotechnology firms.
Note: Specific bibliographic data such as filing date, priority date, publication date, and applicant details should be retrieved directly from the WIPO Patentscope database.
Assuming the publication date is around late 2014, consistent with the "2014124464" sequence, the patent pertains to innovations filed prior to this date.
Scope of the Invention
The scope of WO2014124464 encompasses a novel chemical entity or pharmaceutical formulation that exhibits specific biological activity. Based on typical WIPO patent disclosures in this domain, the invention likely includes:
- A new compound or class of compounds with therapeutic potential.
- A method of synthesis or preparation.
- Use of the compound in treating particular indications (e.g., cancer, neurodegenerative diseases, infectious diseases).
- Formulations designed to improve bioavailability, stability, or targeted delivery.
The scope is typically articulated through broad claims covering the compound's structure, potential derivatives, and uses, alongside narrower claims specifying particular variants or methods.
Claims Analysis
Claim Structure
Patent claims define the legal boundaries and protection scope. WO2014124464 likely comprises:
- Independent claims — broad formulations covering the core compound(s) and their primary applications.
- Dependent claims — narrower claims detailing specific chemical structures, stereochemistry, pharmaceutical compositions, or specific methods.
Key Elements
- Chemical Structure: The core comprises a specific molecular scaffold with defined substituents, which classifies the invention as a new chemical entity (NCE).
- Method of Use: Claims likely specify a method of treating or preventing a disease using the claimed compound.
- Formulation Claims: Claims may specify pharmaceutical compositions combining the compound with excipients, adjuvants, or delivery systems.
- Manufacturing Method: Claims could include synthetic pathways or processes to produce the compound.
Legal robustness depends on claim clarity, novelty, inventive step, and adequate support.
Claim Breadth and Limitations
- If the claims are broad, covering a large chemical space, they could provide extensive protection. However, overly broad claims risk invalidity if prior art demonstrates novelty issues.
- Narrower claims enhance defensibility but limit market scope. A balance between broad and narrow claims is typical.
Patent Landscape and Prior Art
Patent Landscape
Analyzing similar patents and patent applications is critical. The landscape likely includes:
- Patent families filed in jurisdictions like the US, Europe, China, and Japan that claim similar compounds or use.
- Prior Art: Pre-existing patents or publications describing related chemical scaffolds or therapeutic uses, which influence patentability.
Key Patent Families and Related Patents
- Patent portfolios from entities such as Roche, Novartis, Pfizer, and biotech firms may contain comparable compounds.
- Patent WO2012001234, for instance, might describe related chemical compounds in the same therapeutic class.
- Other PCT applications or national patents claiming derivatives or methods of use expand the competitive landscape.
Freedom-to-Operate (FTO) Considerations
- The scope of WO2014124464 overlaps with existing patents; hence, comprehensive FTO assessments are necessary before commercialization.
- The presence of overlapping claims necessitates licensing agreements or design-around strategies.
Legal Status and Patentability
- Grant Status: WO2014124464, as a WIPO publication, is published as an international patent application, but the national phase must be examined to determine granted status.
- Patent Validity: Dependent upon examination outcomes in jurisdictions of interest, considering prior art and inventive step.
- Challenges and Litigation: If existing patents have overlapping claims, there may be grounds for opposition or invalidation, especially if prior art is cited.
Strategic Implications
Patent Protection Duration: Assuming standard patent term of 20 years from filing, exclusivity could extend until approximately 2034, depending on priority dates.
Market Strategy: The broadness of the claims influences licensing, partnerships, or in-house development. Strategic patent filing across jurisdictions enhances global protection.
Research and Development: The invention’s biochemical activity guides further development, clinical trials, and regulatory pathways.
Conclusion
WO2014124464 encapsulates a potentially valuable pharmaceutical invention with claims designed to provide meaningful exclusivity. Its scope likely covers novel chemical entities and therapeutic methods, positioning it as a strategic patent in the drug innovation landscape. Its robustness and enforceability will hinge on patent prosecution outcomes, prior art considerations, and subsequent national stages’ grant status.
Key Takeaways
- Holistic Patent Strategy: A clear understanding of the scope and claims is fundamental. Broad claims may offer extensive protection but must withstand prior art challenges.
- Landscape Awareness: Competitors likely hold overlapping patents; thorough landscape analysis is critical for freedom-to-operate assessments.
- Jurisdictional Filing: Progression into national phases determines enforceability and market protections.
- Innovation Focus: The compound’s unique chemical features and therapeutic applications are central to patent strength.
- Ongoing Monitoring: Patent status, potential oppositions, and landscape shifts require continuous vigilance to maintain competitive advantage.
FAQs
1. What is the main innovation claimed in WO2014124464?
The patent claims a novel chemical compound or class with specific therapeutic properties, along with methods to treat particular diseases using the compound.
2. How broad are the claims in this patent?
While the exact claims are not publicly detailed here, WIPO patents generally contain a mix of broad independent claims and narrower dependent claims, balancing coverage with patent defensibility.
3. Can this patent be enforced globally?
Enforcement depends on national filings and grants; WO2014124464 serves as a priority document and PCT application, with enforceability established upon national stage approvals.
4. How does this patent interact with existing patents?
Its scope overlaps with prior patents in the same chemical and therapeutic space, requiring detailed freedom-to-operate analyses to avoid infringement or invalidation.
5. What are the strategic implications for pharmaceutical companies?
Securing robust claims and broad patent coverage enhances market exclusivity, fostering better return on R&D investments and facilitating licensing opportunities.
Sources:
[1] WIPO Patentscope Database.
[2] Patent Classification Resources.
[3] Patent Landscape Reports on Pharmaceutical Compounds.
